Point mutations in topoisomerase I alter the mutation spectrum in E. coli and impact the emergence of drug resistance genotypes

被引:8
|
作者
Bachar, Amit [1 ]
Itzhaki, Elad [1 ]
Gleizer, Shmuel [1 ]
Shamshoom, Melina [1 ]
Milo, Ron [1 ]
Antonovsky, Niv [1 ,2 ]
机构
[1] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel
[2] Rockefeller Univ, Lab Genet Encoded Small Mol, New York, NY 10065 USA
基金
以色列科学基金会; 欧洲研究理事会;
关键词
ESCHERICHIA-COLI; EVOLUTION; STRAND; MUTATORS; REPEATS; RATES;
D O I
10.1093/nar/gkz1100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Identifying the molecular mechanisms that give rise to genetic variation is essential for the understanding of evolutionary processes. Previously, we have used adaptive laboratory evolution to enable biomass synthesis from CO2 in Escherichia coli. Genetic analysis of adapted clones from two independently evolving populations revealed distinct enrichment for insertion and deletion mutational events. Here, we follow these observations to show that mutations in the gene encoding for DNA topoisomerase I (topA) give rise to mutator phenotypes with characteristic mutational spectra. Using genetic assays and mutation accumulation lines, we find that point mutations in topA increase the rate of sequence deletion and duplication events. Interestingly, we observe that a single residue substitution (R168C) results in a high rate of head-to-tail (tandem) short sequence duplications, which are independent of existing sequence repeats. Finally, we show that the unique mutation spectrum of topA mutants enhances the emergence of antibiotic resistance in comparison to mismatch-repair (mutS) mutators, and leads to new resistance genotypes. Our findings highlight a potential link between the catalytic activity of topoisomerases and the fundamental question regarding the emergence of de novo tandem repeats, which are known modulators of bacterial evolution.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 4 条
  • [1] Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to the Antimalarial Drug Fosmidomycin in E. coli
    Pines, Gur
    Oh, Eun Joong
    Bassalo, Marcelo C.
    Choudhury, Alaksh
    Garst, Andrew D.
    Fankhauser, Reilly G.
    Eckert, Carrie A.
    Gill, Ryan T.
    [J]. ACS SYNTHETIC BIOLOGY, 2018, 7 (12): : 2824 - 2832
  • [2] Impact of marbofloxacin administration on the emergence of marbofloxacin-resistant E. coli in faecal flora of goats and elucidation of molecular basis of resistance
    Bhardwaj, Pallavi
    Kaur, Gurpreet
    Rampal, S.
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 : 116 - 123
  • [3] Impact of MarA Point Mutations on Growth Rate and Susceptibilities to Different Antibiotics of in vitro Generated Mutants of E. coli with Mar Phenotype
    Arntjen, B.
    Heisig, A.
    Heisig, P.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 82 - 82
  • [4] Differential Between Multi-Drug Resistance Pattern of Extended Spectrum beta- Lactamases Producing E. coli and K. pneumoniae
    Ghafourian, Sobhan
    Soheili, Sara
    Aboualigalehdari, Elham
    Sadeghifard, Nourkhoda
    Mohebi, Reza
    Maleki, Abbas
    Hamat, Rukman Awang
    Hosseini, Shiva
    Sekawi, Zamberi
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2014, 8 : 85 - 89